How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

13,521 results for

(coronavir* OR betacoronavir* OR 2019nCoV OR ncov2019 OR nCoV-19 OR ncov OR coronavir* OR COVID OR COVID-19 OR "SARS CoV 2" OR SARSCoV2 OR "corona virus" OR "corona viruses" OR "new cov" OR "novel cov" OR "nouveau cov" OR nCoV2019 OR novel coronavir* OR pandemic* OR "Severe Acute Respiratory Syndrome Coronavirus 2") from:2020 to:2033

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. The Prevalence of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries Full Text available with Trip Pro

The Prevalence of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries The Prevalence of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries by Michael C. Grant, Luke Geoghegan, Marc Arbyn, Zakaria Mohammed, Luke McGuinness, Emily L. Clarke, Ryckie Wade :: SSRN Share: Permalink Using these links (...) of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries 63 Pages Posted: 1 Jun 2020 University of Sheffield Imperial College London - Department of Surgery and Cancer Sciensano University of Leeds - Leeds Institute for Medical Research University of Bristol - Department of Population Health Sciences University of Leeds - Division of Pathology and Data Analytics Leeds Teaching Hospitals Trust, Department

2020 SSRN Electronic Journal

2. [INTERIM ANALYSIS] Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Full Text available with Trip Pro

CRP = C-reactive protein COVID-19 = coronavirus disease ECMO = extracorporeal membrane oxygenation ECG = electrocardiogram FiO2 = oxygen concentration HR = hazard ratio IQR = interquartile range ITT = intention to treat LOC = level of consciousness MAP = mean arterial pressure n = number of patients PaO2 = partial pressure of oxygen p-value = probability value RR = respiratory rate RT-PCR = reverse transcriptase polymerase chain reaction SaO2 = oxygen saturation SARS-CoV-2 = severe acute (...) [INTERIM ANALYSIS] Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK CDEI - Oxford-AstraZeneca COVID-19 Vaccine (Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK — CDEI Open Menu Close Menu Open Menu Close Menu Dec 17 Written By Note: Interim

2021 Covid-19 Drug Evidence Initiative

3. Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic

Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic (April 1, 2020) | The National Academies Press Menu Menu ( 2020 ) View Cover ( 2020 ) × Embed Book Widget Copy the HTML code below to embed this book in your own blog, website, or application. Custom Size: × × Close What is a prepublication? An uncorrected copy, or prepublication (...) , public health, public health preparedness and response, biological sciences, clinical care and crisis standards of care, risk communication, and regulatory issues. This publication responds to questions concerning the possibility that the SARS-Cov-2 virus could be spread by conversation, in addition to sneeze/cough-induced droplets. Suggested Citation National Research Council. 2020. Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic (April 1

2020 Covid-19 Ad hoc papers

4. Rapid Expert Consultation on SARS-CoV-2 Survival and Incubation for the COVID-19 Pandemic

Rapid Expert Consultation on SARS-CoV-2 Survival and Incubation for the COVID-19 Pandemic Rapid Expert Consultation Update on SARS-CoV-2 Surface Stability and Incubation for the COVID-19 Pandemic (March 27, 2020) | The National Academies Press Menu Menu ( 2020 ) View Cover ( 2020 ) × Embed Book Widget Copy the HTML code below to embed this book in your own blog, website, or application. Custom Size: × × Close What is a prepublication? An uncorrected copy, or prepublication, is an uncorrected (...) Citation National Academies of Sciences, Engineering, and Medicine. 2020. Rapid Expert Consultation Update on SARS-CoV-2 Surface Stability and Incubation for the COVID-19 Pandemic (March 27, 2020) . Washington, DC: The National Academies Press. https://doi.org/10.17226/25763. Import this citation to: Publication Info 10 pages | 8.5 x 11 DOI: Contents Search Inside This Book SEARCH Table of Contents skim chapter 1-10 Rights Copyright Information The National Academies Press and the Transportation

2020 Covid-19 Ad hoc papers

5. Canadian Thoracic Society recommendations regarding the use of face masks by the public during the SARS-CoV-2 (COVID-19) pandemic

Canadian Thoracic Society recommendations regarding the use of face masks by the public during the SARS-CoV-2 (COVID-19) pandemic 1 ‘In Press’. Submitted for publication in the CJRCCSM on June 2, 2020. Canadian Thoracic Society recommendations regarding the use of face masks by the public during the SARS-CoV-2 (COVID-19) pandemic Mohit Bhutani a , Paul Hernandez b , Connie Yang c , Jean Bourbeau d , Christopher Licskai e , Gail Dechman f , Anne Van Dam g , Samir Gupta h a Department of Medicine (...) is a rapidly evolving situation and recommendations may change as the science informs us. We recommend to routinely visit our COVID-19 website for updates at https://cts-sct.ca/covid-19. 2 ‘In Press’. Submitted for publication in the CJRCCSM on June 2, 2020. Background As Canada begins to relax the measures instituted to limit the spread of the SARS-CoV-2 virus, recommendations by the Public Health Agency of Canada and local public health authorities are simultaneously evolving to assist in this process

2020 Canadian Thoracic Society

6. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19). Full Text available with Trip Pro

Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19). SARS-CoV-2 is a novel coronavirus and causative pathogen to the pandemic illness COVID-19. Although RNA has been detected in various clinical samples, no reports to date have documented SARS-CoV-2 in human milk. This case report describes an actively breastfeeding patient with COVID-19 infection with detectable viral RNA in human

2020 Clinical Infectious Diseases

7. Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19). Full Text available with Trip Pro

Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) has been declared a pandemic by the World Health Organization and sent all countries scrambling to review emergency healthcare provisions. There is global evidence of each nation struggling to effectively manage the number of people being diagnosed with the virus. These are testing (...) times which have not been experienced in recent generations and there are a number of insecurities regarding the management of people with COVID-19 and cardiometabolic diseases. This review highlights the current concerns related to COVID-19 and provides advice in terms of the therapeutic uncertainty and potential adverse harms associated with therapy when managing people, particularly those with cardiometabolic diseases, who have contracted or are at increased risk of contracting COVID-19.© 2020

2020 obesity & metabolism

8. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid contamination of surfaces on a coronavirus disease 2019 (COVID-19) ward and intensive care unit. Full Text available with Trip Pro

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid contamination of surfaces on a coronavirus disease 2019 (COVID-19) ward and intensive care unit. On coronavirus disease 2019 (COVID-19) wards, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid was frequently detected on high-touch surfaces, floors, and socks inside patient rooms. Contamination of floors and shoes was common outside patient rooms on the COVID-19 wards but decreased after

2020 Infection control and hospital epidemiology

9. COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities Full Text available with Trip Pro

COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities | SpringerLink Search Search SpringerLink Search COVID-19 Severe acute (...) respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities COVID-19 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review of critically unwell children and the association with underlying comorbidities , , , , & , ( 2020 ) 1998 Accesses 16 Altmetric Abstract Data show that children are less severely affected

2020 European journal of pediatrics

10. COVID-19 - SARS-CoV-2

COVID-19 - SARS-CoV-2 1 Chapter 14a - COVID-19 - SARS-Cov-2 Chapter 14a - COVID-19 - SARS-CoV-2 12 February 2021 14a COVID-19 - SARS-CoV-2 NOTIFIABLE The virus COVID-19 disease first emerged as a presentation of severe respiratory infection in Wuhan, China in late 2019 (WHO, 2020). By January 2020, lower respiratory samples taken from affected patients were sequenced and demonstrated a novel coronavirus (SARS-CoV-2) (Huang et al, 2020). The first two cases in the UK were seen in late January (...) , hypertension and asthma, or are 35 years old or older (Vousden et al, 2021, Allotey et al, 2020). 5 Chapter 14a - COVID-19 - SARS-Cov-2 Chapter 14a - COVID-19 - SARS-CoV-2 12 February 2021 COVID-19 vaccines The recognition of the pandemic has accelerated the development and testing of several vaccines using platforms investigated during previous emergencies such as the SARS pandemic (Amanat et al, 2020) and Ebola in West Africa. Candidate vaccines include nucleic acid vaccines, inactivated virus vaccines

2021 The Green Book

11. mRNA-1273 SARS-CoV-2 - Moderna Covid-19 vaccine

mRNA-1273 SARS-CoV-2 - Moderna Covid-19 vaccine Search Page - Drug and Health Product Register Language selection Search and menus Search Search website Search Topics menu You are here: Summary Basis of Decision - - Health Canada Expand all Summary Basis of Decision (SBD) for Contact: Summary Basis of Decision (SBD) documents provide information related to the original authorization of a product. The for is located below. Recent Activity for SBDs written for approved after September 1, 2012

2021 Health Canada - Drug and Health Product Register

12. COVID-19: investigation and management of suspected SARS-CoV-2 reinfections

COVID-19: investigation and management of suspected SARS-CoV-2 reinfections COVID-19: investigation and management of suspected SARS-CoV-2 reinfections - GOV.UK Cookies on GOV.UK We use some essential cookies to make this website work. We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services. We also use cookies set by other sites to help us deliver content from their services. Accept additional cookies Reject additional (...) cookies You can at any time. Hide this message Show or hide search Search on GOV.UK Search Menu National lockdown: stay at home Check what you need to do Guidance COVID-19: investigation and management of suspected SARS-CoV-2 reinfections Steps for investigating and managing individuals who are suspected to be reinfected with SARS-CoV-2. From: Published: 15 March 2021 Applies to: England Documents HTML Details This guidance is for clinicians and infection specialists. It provides details

2021 Public Health England

13. SARS-CoV-2 infection, COVID-19 and timing of elective surgery

. Rhee C, Kanjilal S, Baker M, Klompas M. Duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity: When is it safe to discontinue isolation? Clinical Infectious Diseases 2020; 2: 23–28. 21. World Health Organization. Clinical management of COVID-19. 2021. https://www.who.int/publications/i/item/clinical-management-of-covid-19. 15 22. NHS England. How long to self-isolate. 2020. https://www.nhs.uk/conditions/coronavirus- covid-19/self-isolation-and-treatment/how-long (...) , Simoes JFF, et al. Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study. Journal of Clinical Oncology 2021; 39: 66–78. 16. Kane AD, Paterson J, Pokhrel S, et al. Peri-operative COVID-19 infection in urgent elective surgery during a pandemic surge period: a retrospective observational cohort study. Anaesthesia 2020; 75: 1596–1604. 17. Wilson NM, Norton A, Young FP, Collins DW. Airborne transmission of severe

2021 ICM Anaesthesia COVID-19

14. Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2)

Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2) Terms of use - Canada.ca Language selection Search Search Canada.ca Search Topics menu Main Menu You are here: Terms of use From These Terms of Use govern the access and use of Clinical Information released by Health Canada for non-commercial purposes. By clicking the button “I agree” and accepting these Terms of Use and upon being granted access to the Clinical Information, you, and, if applicable, the organization on behalf of which you

2021 Health Canada - drugs and medical devices

15. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries Full Text available with Trip Pro

of this project. Competing interests: The authors have declared that no competing interests exist. Introduction The novel coronavirus (SARS-CoV-2; 2019-nCoV; COVID-19) pandemic is a global crisis. As of April 10 th 2020, there were over 1.5 million confirmed cases of whom over 92,000 have died [ ]. In the absence of a vaccine or treatment with proven efficacy, limiting human-to-human transmission is critical [ – ]. Self-isolation (or self-quarantine) is an effective global strategy for limiting transmission (...) . Y G., P Y., D Q., C L., L J., L Y., et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. (Ye, Pan, Deng, Chen, Li, Li) Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China: W.B. Saunders Ltd; 2020; 69. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet

2020 PloS one

16. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection Among VA Healthcare System Employees Suggests Higher Risk of Infection When Exposed to SARS-CoV-2 Outside of the Work Environment. Full Text available with Trip Pro

Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection Among VA Healthcare System Employees Suggests Higher Risk of Infection When Exposed to SARS-CoV-2 Outside of the Work Environment. The seroprevalence of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-COV-2) IgG antibody was evaluated among employees of a Veterans Affairs Healthcare System to assess potential risk factors for transmission and infection.All employees were invited to participate (...) on gender, age, frontline worker status, job title, performance of aerosol generating procedures or exposure to known patients with coronavirus infectious disease 2019 (COVID-19) within the hospital. Employees who reported exposure to a known COVID-19 case outside of work had a significantly higher seroprevalence at 14.84% (23/155) compared to those that did not 3.70% (48/1296), OR 4.53 [95% CI 2.67-7.68] p<0.0001. Notably, 29% of seropositive employees reported no history of symptoms for SARS-CoV-2

2020 Infection control and hospital epidemiology

17. SARS-CoV-2 viral load and the severity of COVID-19 Full Text available with Trip Pro

of the Second and Third Wave of 1918–1919 Influenza Pandemic. infection (mean age, 72±16 years) reported major comorbidities and systemic corticosteroid were associated with slower viral clearance. Severe cases of influenza have more active and prolonged viral replication. Healthcare Workers. Reports across several countries report healthcare workers are more at risk of catching SARS-CoV-2 and potentially more severe. having COVID-19 disease. We use multiple sources as there is considerable variation (...) SARS-CoV-2 viral load and the severity of COVID-19 SARS-CoV-2 viral load and the severity of COVID-19 - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website SARS-CoV-2 viral load and the severity of COVID-19 March 26, 2020 Carl Heneghan, Jon Brassey, Tom Jefferson Oxford COVID-19 Evidence Service Team Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences University of Oxford

2020 Oxford COVID-19 Evidence Service

18. Is there any significant difference in sensitivity of COVID-19 virus (SARS-CoV-2) tests based on swabs from oropharyngeal (OP) vs nasopharyngeal (NP) sampling vs both?

recommending collecting only nasopharyngeal swabs (NP), not NP and oropharyngeal swabs (OP). However, OP would be easier to do without training than NP, so one question is whether there is a significant difference in sensitivity between the two methods or using them in combination. SEARCH STRATEGY Search terms: COVID-19, SARS-CoV-2, wuhan coronavirus, 2019-nCoV, 2019nCoV, nasopharyngeal, oropharyngeal, swab, diagnosis, diagnostic, test, sensitivity Databases: PubMed, Embase, Web of Science, Scopus (...) Is there any significant difference in sensitivity of COVID-19 virus (SARS-CoV-2) tests based on swabs from oropharyngeal (OP) vs nasopharyngeal (NP) sampling vs both? Comparative accuracy of oropharyngeal and nasopharyngeal swabs for diagnosis of COVID-19 - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Comparative accuracy of oropharyngeal and nasopharyngeal swabs for diagnosis of COVID-19 March 26

2020 Oxford COVID-19 Evidence Service

19. COVID-19: Do weather conditions influence the transmission of the coronavirus (SARS-CoV-2)?

-2021 winter season”. Another found that the current spread suggests a preference for cool and dry conditions. They also report that the 2002-3 SARS-CoV outbreak was linked to similar climate conditions. If the COVID-19 pandemic follows SARS CoV-2 trends, then a worst-case scenario of a synchronous global pandemic would appear unlikely. The authors report that asynchronous seasonal global outbreaks were much likelier. of the SARS outbreak in Hong Kong, Guangzhou, Beijing, and Taiyuan found (...) COVID-19: Do weather conditions influence the transmission of the coronavirus (SARS-CoV-2)? Do weather conditions influence the transmission of the coronavirus (SARS-CoV-2) - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Do weather conditions influence the transmission of the coronavirus (SARS-CoV-2) Jon Brassey, Carl Heneghan, Kamal R. Mahtani, Jeffrey K. Aronson On behalf of the Oxford COVID-19

2020 Oxford COVID-19 Evidence Service

20. COVID-19: Spreading SARS-CoV-2 through ocular fluids

COVID-19: Spreading SARS-CoV-2 through ocular fluids Maximising mobility in the elderly when isolated with COVID-19 - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Maximising mobility in the elderly when isolated with COVID-19 JAMIE HARTMANN-BOYCE 20/03/2020 On behalf of the Oxford COVID-19 Evidence Service Team Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences

2020 Oxford COVID-19 Evidence Service

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>